Dec 5, 2024
Earlier this week, Neola Medical participated in the Redeye Technology and Life Science Day in Stockholm, showcasing the company’s significant progress and outlining its future plans during an engaging presentation and dynamic Q&A session. Discover deeper...
Nov 27, 2024
Yesterday CEO Hanna Sjöström showcased Neola Medical’s vision and strategic advancements during the presentation at Stora Aktiedagarna in Stockholm, highlighting the future of neonatal care. The presentation was met with great interest, filling the room with engaged...
Nov 15, 2024
Did you miss CEO Hanna Sjöström’s investor presentation at the Redeye Theme: Medtech & Diagnostics Event 2024? Don’t worry—you can still catch up on all the exciting updates! In her presentation, CEO Hanna Sjöström highlighted Neola Medical’s significant...
Nov 6, 2024
Watch when CEO Hanna Sjöström and CFO David Folkesson presented Neola Medical’s Q3-report of 2024. Learn more about the company’s financial position and the progress from this quarter, toward market approval in the U.S. After the presentation a brief Q&A follows....
Aug 23, 2024
The company’s product for continuous lung monitoring of preterm born infants is attracting significant international interest. Watch CEO Hanna Sjöström and CEO Oscar Ahlgren at Västra Hamnen TV discuss Neola Medical’s promising study data, the substantial...
Aug 16, 2024
The second quarter of 2024 marked several milestones towards achieving market approval in the U.S. Notably, the company’s medical device received CB certification, indicating that Neola®meets the required technical safety standards. Clinical trials are now on...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPersonal Data Policy
